soul trial oral semaglutide cardiovascular outcomes results A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link SOUL (Semaglutide cardiOvascular oUtcomes triaL)
Description
The SUSTAIN clinical trial program demonstrated the effectiveness of Ozempic for weight loss in patients with type 2 diabetes
Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women
But what if there were medications and programs designed to help you reach your goals safely and effectively
An investigation into the mechanisms underlying these therapeutic effects revealed that semaglutide significantly increased levels of key neuroprotective molecules while decreasing those involved in pro-neurodegenerative pathways
Tara Narula explains what to know about retatrutide and the latest clinical trial results.
